Discontinued — last reported Q4 '19
Products & Services · Revenue
ELOCTATE — Revenue
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2016
Last reportedQ4 2019
Rolls up toTotal Revenue
How to read this metric
An increase indicates strong market penetration and patient retention for the therapy, while a decrease may signal increased competition, loss of patent exclusivity, or shifts in treatment standards.
Detailed definition
This metric represents the total net sales generated from the commercialization of the specific hemophilia therapy produ...
Peer comparison
Comparable to product-specific revenue lines reported by other biopharmaceutical companies focused on rare diseases or specialty hematology franchises.
Metric ID:
biib_segment_eloctate_revenuesSimilar Metrics at Other Companies
Frequently Asked Questions
- What does eloctate — revenue mean?
- The total revenue earned from sales of the specified hemophilia treatment product.